Works matching AU Greil, Richard


Results: 244
    1

    Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00580-3
    By:
    • Lafarge, Maxime W.;
    • Domingo, Enric;
    • Sirinukunwattana, Korsuk;
    • Wood, Ruby;
    • Samuel, Leslie;
    • Murray, Graeme;
    • Richman, Susan D.;
    • Blake, Andrew;
    • Sebag-Montefiore, David;
    • Gollins, Simon;
    • Klieser, Eckhard;
    • Neureiter, Daniel;
    • Huemer, Florian;
    • Greil, Richard;
    • Dunne, Philip;
    • Quirke, Philip;
    • Weiss, Lukas;
    • Rittscher, Jens;
    • Maughan, Tim;
    • Koelzer, Viktor H.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.

    Published in:
    2012
    By:
    • Schimanski, Carl Christoph;
    • Möhler, Markus;
    • Schön, Michael;
    • van Cutsem, Eric;
    • Greil, Richard;
    • Bechstein, Wolf Otto;
    • Hegewisch-Becker, Susanna;
    • von Wichert, Götz;
    • Vöhringer, Matthias;
    • Heike, Michael;
    • Heinemann, Volker;
    • Peeters, Marc;
    • Kanzler, Stephan;
    • Kasper, Stefan;
    • Overkamp, Friedrich;
    • Schröder, Jan;
    • Seehofer, Daniel;
    • Kullmann, Frank;
    • Linz, Bernhard;
    • Schmidtmann, Irene
    Publication type:
    journal article
    20
    21
    22
    23
    24

    A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha‐2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)—AGMT_CML 1

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 792, doi. 10.1002/hon.2786
    By:
    • Heibl, Sonja;
    • Buxhofer‐Ausch, Veronika;
    • Schmidt, Stefan;
    • Webersinke, Gerald;
    • Lion, Thomas;
    • Piringer, Gudrun;
    • Kuehr, Thomas;
    • Wolf, Dominik;
    • Melchardt, Thomas;
    • Greil, Richard;
    • Thaler, Josef
    Publication type:
    Article
    25

    Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3051, doi. 10.1007/s00432-022-04096-w
    By:
    • Huemer, Florian;
    • Hecht, Stefan;
    • Scharinger, Bernhard;
    • Schlintl, Verena;
    • Rinnerthaler, Gabriel;
    • Schlick, Konstantin;
    • Heregger, Ronald;
    • Melchardt, Thomas;
    • Wimmer, Angela;
    • Mühlbacher, Iris;
    • Koch, Oliver Owen;
    • Neureiter, Daniel;
    • Klieser, Eckhard;
    • Seyedinia, Sara;
    • Beheshti, Mohsen;
    • Greil, Richard;
    • Weiss, Lukas
    Publication type:
    Article
    26
    27
    28
    29

    Inactivation of TRPM7 Kinase Targets AKT Signaling and Cyclooxygenase-2 Expression in Human CML Cells.

    Published in:
    Function, 2023, v. 4, n. 6, p. 1, doi. 10.1093/function/zqad053
    By:
    • Hoeger, Birgit;
    • Nadolni, Wiebke;
    • Hampe, Sarah;
    • Hoelting, Kilian;
    • Fraticelli, Marco;
    • Zaborsky, Nadja;
    • Madlmayr, Anna;
    • Sperrer, Viktoria;
    • Fraticelli, Laura;
    • Addington, Lynda;
    • Steinritz, Dirk;
    • Chubanov, Vladimir;
    • Geisberger, Roland;
    • Greil, Richard;
    • Breit, Andreas;
    • Boekhoff, Ingrid;
    • Gudermann, Thomas;
    • Zierler, Susanna
    Publication type:
    Article
    30
    31

    Association between SARS‐CoV‐2 viral kinetics and clinical score evolution in hospitalized patients.

    Published in:
    CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 12, p. 2027, doi. 10.1002/psp4.13051
    By:
    • Néant, Nadège;
    • Lingas, Guillaume;
    • Gaymard, Alexandre;
    • Belhadi, Drifa;
    • Hites, Maya;
    • Staub, Thérèse;
    • Greil, Richard;
    • Paiva, Jose‐Artur;
    • Poissy, Julien;
    • Peiffer‐Smadja, Nathan;
    • Costagliola, Dominique;
    • Yazdanpanah, Yazdan;
    • Bouscambert‐Duchamp, Maude;
    • Gagneux‐Brunon, Amandine;
    • Ader, Florence;
    • Mentré, France;
    • Wallet, Florent;
    • Burdet, Charles;
    • Guedj, Jérémie
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Normative Data for Functional Assessment of Cancer Therapy.

    Published in:
    Acta Oncologica, 2004, v. 43, n. 2, p. 153, doi. 10.1080/02841860310023453
    By:
    • Holzner, Bernhard;
    • Kemmler, Georg;
    • Cella, David;
    • de Paoli, Christina;
    • Meraner, Verena;
    • Kopp, Martin;
    • Greil, Richard;
    • Fieischhacker, W. Wolfgang;
    • Sperner-Unterweger, Barbara
    Publication type:
    Article
    38
    39
    40
    41
    42
    43

    Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma

    Published in:
    2023
    By:
    • Nowakowski, Grzegorz S.;
    • Yoon, Dok Hyun;
    • Mondello, Patrizia;
    • Joffe, Erel;
    • Peters, Anthea;
    • Fleury, Isabelle;
    • Greil, Richard;
    • Ku, Matthew;
    • Marks, Reinhard;
    • Kim, Kibum;
    • Zinzani, Pier Luigi;
    • Trotman, Judith;
    • Sabatelli, Lorenzo;
    • Waltl, Eva E.;
    • Winderlich, Mark;
    • Sporchia, Andrea;
    • Kurukulasuriya, Nuwan C.;
    • Cordoba, Raul;
    • Hess, Georg;
    • Salles, Gilles
    Publication type:
    Correction Notice
    44

    RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma

    Published in:
    Annals of Hematology, 2023, v. 102, n. 7, p. 1773, doi. 10.1007/s00277-023-05196-4
    By:
    • Nowakowski, Grzegorz S.;
    • Yoon, Dok Hyun;
    • Mondello, Patrizia;
    • Joffe, Erel;
    • Peters, Anthea;
    • Fleury, Isabelle;
    • Greil, Richard;
    • Ku, Matthew;
    • Marks, Reinhard;
    • Kim, Kibum;
    • Zinzani, Pier Luigi;
    • Trotman, Judith;
    • Sabatelli, Lorenzo;
    • Waltl, Eva E.;
    • Winderlich, Mark;
    • Sporchia, Andrea;
    • Kurukulasuriya, Nuwan C.;
    • Cordoba, Raul;
    • Hess, Georg;
    • Salles, Gilles
    Publication type:
    Article
    45
    46

    PET-guided Treatment in Patients with Advanced-stage Hodgkin's Lymphoma (HD18): Final Results of An Open-label, International, Randomised Phase 3 Trial by the German Hodgkin Study Group.

    Published in:
    Indian Journal of Chest Diseases & Allied Sciences, 2018, v. 60, n. 1, p. 44
    By:
    • Borchmann, Peter;
    • Goergen, Helen;
    • Kobe, Carsten;
    • Lohri, Andreas;
    • Greil, Richard;
    • Eichenauer, Dennis A.;
    • Zijlstra, Josée M.;
    • Markova, Jana;
    • Meissner, Julia;
    • Feuring-Buske, Michaela;
    • Hüttmann, Andreas;
    • Dierlamm, Judith;
    • Soekler, Martin;
    • Beck, Hans-Joachim;
    • Willenbacher, Wolfgang;
    • Ludwig, Wolf-Dieter;
    • Pabst, Thomas;
    • Topp, Max S.;
    • Hitz, Felicitas;
    • Bentz, Martin
    Publication type:
    Article
    47
    48
    49
    50